Researchers Pioneer Revolutionary Method for Treating Chronic Abdominal Pain
A research team from the University of Vienna, headed by medicinal chemist Markus Muttenthaler, has introduced a novel class of oral peptide therapeutic candidates to address chronic abdominal pain. This innovative approach provides a safe, non-opioid alternative for managing conditions like irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD), which impact millions globally. The […]
Researchers Pioneer Revolutionary Method for Treating Chronic Abdominal Pain Read More »









